The purpose of this study is to determine whether acceptance and commitment therapy is effective in the treatment of SSRIs-resistant obsessive- compulsive disorder.
The patients who were SSRI-resistant will be randomized to ACT, aripiprazole, or SMT. Independent evaluators, blind to treatment,will evaluate patients during the study.The Yale-Brown Obsessive Compulsive Scale (YBOCS)will be used to measure OCD severity.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Patients randomized to ACT will receive weekly 45-50 minute sessions delivered over 8 weeks by a therapist. ACT will include mindfulness,learning new methods to handle problems,acceptance of thoughts and feelings, learning to disempower thoughts and feelings, and values-based committed action.
Patients randomized to aripiprazole group will be treated with aripiprazole at the dose of 10-20mg/day for 8 weeks.
Patients randomized to SMT group will be received 2 introductory sessions and 15 treatment sessions. SMT will include training of stress manage-ment skills, progressive muscle relaxation,positive imagery, assertiveness training, and problem solving.
Yale Brown Obsessive Compulsive Scale
Change from baseline Y-BOCS score at 8 weeks
Time frame: 0,8week
Beck Depression Inventory
Time frame: 0,8week
Acceptance and Action Questionnaire
Time frame: 0,8week
Treatment Evaluation Inventory-Short Form
Time frame: 0,8week
Basic life sign
Time frame: 0,8week
BMI
Time frame: 0,8week
Abnormal Involuntary Movement Scale
Time frame: 0,8week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.